Abstract
Laryngopharyngeal reflux (LPR) is characterized by the reflux of gastric contents into the pharynx or larynx and often presents with symptoms including but not limited to cough, throat clearing, sore throat, globus, and dysphonia. Unlike gastroesophageal reflux disease (GERD), LPR is a relatively understudied syndrome, and knowledge regarding the diagnostic and treatment strategies, as well as the psychosocial impact continues to evolve. No singular test or procedure currently exists as a gold standard for LPR diagnosis. While laryngoscopy or pH monitoring may be positive, this does not exclude the contribution of non-gastroenterological processes. Prior research into psychosocial impact demonstrates a significant increase in symptom burden when comparing patients with laryngeal symptoms to controls and those with isolated GERD symptoms. However, these data are limited by the absence of physiologic data to correlate with the reported symptoms and survey responses. This knowledge gap highlights the need for further research to investigate the relationship between symptom burden and pathologic acid reflux on quality of life (QOL), anxiety, and depression. Ultimately, future studies to directly analyze these variables will help to guide treatment strategies and improve QOL in these patients.
Graphical Abstract
Similar content being viewed by others
References
Krause AJ, Walsh EH, Weissbrod PA, Taft TH, Yadlapati R. An update on current treatment strategies for laryngopharyngeal reflux symptoms. Ann N Y Acad Sci. 2022;1510:5–17. https://doi.org/10.1111/nyas.14728.
Brown HJ, Kuhar HN, Plitt MA, Husain I, Batra PS, Tajudeen BA. The Impact of Laryngopharyngeal Reflux on Patient-reported Measures of Chronic Rhinosinusitis. Ann Otol Rhinol Laryngol. 2020;129:886–893. https://doi.org/10.1177/0003489420921424.
Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117:27–56. https://doi.org/10.14309/ajg.0000000000001538.
Lenderking WR, Hillson E, Crawley JA, Moore D, Berzon R, Pashos CL. The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life. Value Health 2003;6:560–565. https://doi.org/10.1046/j.1524-4733.2003.65243.x.
Krause AJ, Greytak M, Burger ZC, Taft T, Yadlapati R. Hypervigilance and Anxiety are Elevated Among Patients With Laryngeal Symptoms With and Without Laryngopharyngeal Reflux. Clin Gastroenterol Hepatol. Oct 26 2022;doi:https://doi.org/10.1016/j.cgh.2022.10.017
Yadlapati R, Gyawali CP, Pandolfino JE. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Clin Gastroenterol Hepatol. 2022;20:984-994.e1. https://doi.org/10.1016/j.cgh.2022.01.025.
Brazier JE, Harper R, Jones NM et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Bmj. 1992;305:160–164. https://doi.org/10.1136/bmj.305.6846.160.
Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016;4:2050312116671725. https://doi.org/10.1177/2050312116671725.
Shah CH, Brown JD. Reliability and Validity of the Short-Form 12 Item Version 2 (SF-12v2) Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population. J Clin Med. Feb 29 2020;9. doi:https://doi.org/10.3390/jcm9030661
Soh SE, Morello R, Ayton D, et al (2021) Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: a Rasch analysis. Health Qual Life Outcomes 19:157. doi: https://doi.org/10.1186/s12955-021-01794-w
Djukanovic I, Carlsson J, Årestedt K. Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65–80 years old? A psychometric evaluation study. Health Qual Life Outcomes. Oct 4 2017;15:193. doi:https://doi.org/10.1186/s12955-017-0759-9
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. Feb 2002;52:69–77. doi:https://doi.org/10.1016/s0022-3999(01)00296-3
Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34:447–454. https://doi.org/10.1111/j.1749-4486.2009.01995.x.
Toma S, Hopkins C. Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology. 2016;54:129–133. https://doi.org/10.4193/Rhino15.072.
Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16:274–277. https://doi.org/10.1016/s0892-1997(02)00097-8.
Abraham ZS, Kahinga AA. Utility of reflux finding score and reflux symptom index in diagnosis of laryngopharyngeal reflux disease. https://doi.org/10.1002/lio2.799. Laryngoscope Investigative Otolaryngology. 2022/06/01 2022;7:785–789. doi:https://doi.org/10.1002/lio2.799
Murry T, Rosen CA. Outcome measurements and quality of life in voice disorders. Otolaryngol Clin North Am. 2000;33:905–916. https://doi.org/10.1016/s0030-6665(05)70251-6.
Kim SI, Kwon OE, Na SY, Lee YC, Park JM, Eun YG. Association between 24-hour combined multichannel intraluminal impedance-pH monitoring and symptoms or quality of life in patients with laryngopharyngeal reflux. Clin Otolaryngol. 2017;42:584–591. https://doi.org/10.1111/coa.12817.
Carrau RL, Khidr A, Gold KF et al. Validation of a quality-of-life instrument for laryngopharyngeal reflux. Arch Otolaryngol Head Neck Surg. 2005;131:315–320. https://doi.org/10.1001/archotol.131.4.315.
McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. Health Qual Life Outcomes. Sep 20 2016;14:133. doi:https://doi.org/10.1186/s12955-016-0537-0
Taft TH, Triggs JR, Carlson DA et al. Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease. Aliment Pharmacol Ther. 2018;47:1270–1277. https://doi.org/10.1111/apt.14605.
Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope. 2004;114:670–674. https://doi.org/10.1097/00005537-200404000-00014.
Cheung TK, Lam PK, Wei WI et al. Quality of life in patients with laryngopharyngeal reflux. Digestion. 2009;79:52–57. https://doi.org/10.1159/000205267.
Lechien JR, Finck C, Huet K, et al. Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study. European Archives of Oto-Rhino-Laryngology. 2017/10/01 2017;274:3687–3696. doi:https://doi.org/10.1007/s00405-017-4671-z
Siupsinskiene N, Adamonis K, Toohill RJ. Quality of life in laryngopharyngeal reflux patients. Laryngoscope. 2007;117:480–484. https://doi.org/10.1097/MLG.0b013e31802d83cf.
Gong EJ, Choi KD, Jung HK et al. Quality of life, patient satisfaction, and disease burden in patients with gastroesophageal reflux disease with or without laryngopharyngeal reflux symptoms. J Gastroenterol Hepatol. 2017;32:1336–1340. https://doi.org/10.1111/jgh.13716.
Koufman JA. Low-acid diet for recalcitrant laryngopharyngeal reflux: therapeutic benefits and their implications. Ann Otol Rhinol Laryngol. 2011;120:281–287. https://doi.org/10.1177/000348941112000501.
Campagnolo AM, Priston J, Thoen RH, Medeiros T, Assunção AR. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol. 2014;18:184–191. https://doi.org/10.1055/s-0033-1352504.
Acknowledgments
None.
Funding
This work was supported by NIH 5T32DK007202 (Ghosh, PI); NIH K23 DK125266 (Yadlapati, PI); NIH R03 DK135513 (Yadlapati, PI).
Author information
Authors and Affiliations
Contributions
KL, AJK, and RY contributed to manuscript outline, literature review, drafting of the manuscript, critical revisions of the manuscript for important intellectual content, and approval of the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
RY has served as a consultant for Medtronic, Ironwood Pharmaceuticals, Phathom Pharmaceuticals, StatLink MD and Medscape. RY has received research support from Ironwood Pharmaceuticals. RY has served on advisory boards for RJS Mediagnostix with stocks.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, K., Krause, A. & Yadlapati, R. Quality of Life and Laryngopharyngeal Reflux. Dig Dis Sci 68, 3527–3533 (2023). https://doi.org/10.1007/s10620-023-08027-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-08027-8